pentosidine has been researched along with neopterin in 3 studies
| Studies (pentosidine) | Trials (pentosidine) | Recent Studies (post-2010) (pentosidine) | Studies (neopterin) | Trials (neopterin) | Recent Studies (post-2010) (neopterin) |
|---|---|---|---|---|---|
| 577 | 34 | 205 | 2,628 | 214 | 629 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Descamps-Latscha, B; Friedlander, MA; Jungers, P; Labrunte, M; Nguyen, AT; Verger, C; Witko-Sarsat, V; Wu, YC | 1 |
| Hricik, DE; Justice, AC; Rodby, RA; Weiss, MF | 1 |
| Braun, M; Celec, P; Halčák, L; Hodosy, J; Holzerová, J; Janega, P; Jáni, P; Kalousová, M; Kúdela, M; Murín, J; Parrák, V; Pecháň, I; Šebeková, K; Zima, T | 1 |
1 trial(s) available for pentosidine and neopterin
| Article | Year |
|---|---|
Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Collaborative Study Group.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Arginine; Biomarkers; Captopril; Creatinine; Cross-Linking Reagents; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Lysine; Male; Neopterin; Predictive Value of Tests; Survival Analysis | 1998 |
2 other study(ies) available for pentosidine and neopterin
| Article | Year |
|---|---|
The advanced glycation endproduct pentosidine and monocyte activation in uremia.
Topics: Arginine; Biomarkers; Biopterins; Chromatography, High Pressure Liquid; Cross-Linking Reagents; Disease Progression; Glycation End Products, Advanced; Humans; Kidney Failure, Chronic; Lysine; Monocytes; Neopterin; Peritoneal Dialysis; Radioimmunoassay; Renal Dialysis; Uremia | 1996 |
Advanced glycation end products in myocardial reperfusion injury.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Arginine; Cardiac Surgical Procedures; Disease Models, Animal; Fasting; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Neopterin; Rabbits; Stroke Volume; Thrombolytic Therapy; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left; Young Adult | 2012 |